What Are the Stages of Pleural Mesothelioma?
Pleural mesothelioma is staged using the TNM system, developed by the American Joint Committee on Cancer. TNM stands for Tumor, Node, and Metastasis. Each component describes a different aspect of how far the cancer has spread, and together they determine the overall stage assigned at diagnosis.
- Tumor (T) describes the size and location of the primary tumor
- Node (N) indicates whether cancer has reached the lymph nodes
- Metastasis (M) identifies whether the cancer has spread to distant organs
Based on these three factors, pleural mesothelioma is classified into four stages.
Stage I Pleural Mesothelioma
Stage I is the earliest stage of pleural mesothelioma. The tumor is confined to the lining of the chest on one side and has not spread to the lymph nodes or anywhere else in the body. On imaging, the tumor appears thin and has not grown into the tissue between the lungs.
Symptoms at this stage are often mild or absent entirely, which is part of why early diagnosis is uncommon. When symptoms do appear, they typically include shortness of breath, a persistent cough, or mild chest discomfort. Patients with a known history of asbestos exposure who notice any of these signs should consult a physician promptly.
Stage II Pleural Mesothelioma
At Stage II, the tumor remains on the same side of the chest with no lymph node involvement and no spread to other parts of the body, but it has grown larger or begun to extend into nearby tissue. This may include growth into the tissue between the lungs, the fat around the heart, or a small area of the chest wall.
Symptoms become more noticeable at this stage. Patients commonly experience increased chest pain, difficulty breathing, mild fatigue, and fluid buildup around the lungs, known as pleural effusion. These symptoms are more persistent than in Stage I and less likely to be dismissed as minor.
Stage IIIA Pleural Mesothelioma
Stage IIIA covers a wide range of more advanced disease. The tumor may have grown significantly larger, spread to lymph nodes on the same side of the chest, or both. Surgery is generally not an option at this stage.
Symptoms are more pronounced and harder to manage. Patients typically experience worsening breathlessness, severe chest pain, unexplained weight loss, night sweats, and increasing fatigue. The shift from Stage II to Stage IIIA often marks a meaningful change in both how the disease feels and which treatments are available.
Stage IIIB Pleural Mesothelioma
Stage IIIB is reached when the tumor has grown into critical structures in the chest, regardless of whether the lymph nodes are involved. This includes invasion of the chest wall bone, the heart, major blood vessels, the esophagus or trachea, or when the tumor has pushed through the diaphragm or the sac surrounding the heart. Spread to the lining of the opposite lung also places the disease at this stage, as does the presence of malignant fluid around the heart. Surgery is not an option at this stage.
Symptoms are severe. Patients typically experience intense chest pain, significant difficulty breathing, unexplained weight loss, and marked fatigue. Treatment at this stage focuses on disease control and quality of life.
Stage IV Pleural Mesothelioma
Stage IV is the most advanced stage of pleural mesothelioma. It is defined by spread to distant parts of the body outside the chest, such as the liver, bones, or other organs, regardless of tumor size or lymph node involvement. Surgery is not an option at this stage.
Symptoms are severe and significantly impact daily life. Patients typically experience extreme difficulty breathing, intense pain, severe weight loss, loss of appetite, and a marked overall decline in health. Treatment at this stage may still include first-line systemic therapy, including immunotherapy combinations.
How Mesothelioma Stage Affects Treatment Options
Stage at diagnosis is one of the primary factors that shape a patient’s treatment plan. As the disease progresses, the range of available options narrows and the goals of treatment shift.
- Stage I: The earliest stage, with the most favorable prognosis. In select cases, particularly patients with Stage I disease and epithelioid cell type, surgical evaluation may be considered, though systemic therapy with or without radiation is the preferred approach per current guidelines. Patients should discuss all options with a mesothelioma specialist.
- Stage II: Surgery is generally not pursued at this stage. Treatment typically involves systemic therapy, including chemotherapy, immunotherapy, or a combination of both, or observation for patients with low disease burden and no symptoms.
- Stage IIIA: Surgery is not an option at this stage. Treatment focuses on slowing disease progression through systemic therapies, including chemotherapy and immunotherapy, as well as clinical trials, along with palliative care to manage symptoms.
- Stage IIIB: Surgery is not an option at this stage. The tumor has grown into critical structures in the chest. Treatment focuses on disease control through systemic therapy, palliative care, and clinical trial options.
- Stage IV: Active treatment is still an option at this stage. First-line systemic therapy, including immunotherapy combinations, may be offered to control the disease and extend meaningful time. Palliative care and clinical trials are also central to the treatment plan.
How an Asbestos Guide Can Help
Understanding your stage is just the beginning. What comes next, whether that means finding a specialist, understanding your treatment options, or learning what financial support is available, can feel overwhelming without someone to help you navigate it.
That’s what an Asbestos Guide is for. Reach out today for a conversation at no cost and no obligation.